Why Aren't Stocks Sweating Trump's COVID Stimulus Snub?
President Trump decries $600 stimulus payments in COVID rescue bill, putting its passage in doubt. Here's why the market isn't shaking yet.
President Donald Trump surprised most of America on Tuesday night when he spoke out against the $900 billion COVID stimulus bill recently approved by Congress, putting its full passage into question.
And yet, the stock market barely budged Wednesday morning. Dow Jones Industrial Average, S&P 500 and Nasdaq Composite futures were all in the black heading into the day's trading session.
Specifically, Trump didn't outright threaten to veto the plan, which includes $600 stimulus checks. But he did call it a "disgrace" and urged Congress to up the amount to $2,000 per American. He also rallied against "unnecessary items from this legislation," seeming to confuse the coronavirus rescue package and the omnibus spending bill that was passed alongside it.
From just $107.88 $24.99 for Kiplinger Personal Finance
Become a smarter, better informed investor. Subscribe from just $107.88 $24.99, plus get up to 4 Special Issues
Sign up for Kiplinger’s Free Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
Nonetheless, this threatens to at least delay much-needed relief to American individuals and small businesses, the latter of which was expected to benefit from access to another $285 million in the restarted Paycheck Protection Program (PPP).
So why does the stock market appear so sanguine?
"The possibility of a failed stimulus deal means almost nothing for the stock market because stocks still rose over the past few months when there was no stimulus and no likelihood of one coming," says David Bahnsen, chief investment officer of California-based The Bahnsen Group. "The market didn't move up much in recent days when a deal was finalized, before this latest speed bump in passing a stimulus deal."
He believes that the stock market still expects some sort of stimulus to happen, regardless of the form it takes.
"While I believe there are sufficient votes to override a veto from President Trump," he says, "I also believe President Trump could actually get what he wants in a revision of the stimulus deal."
Raymond James analysts agree that the president's demands for revisions to the COVID relief bill "raise the individual payment amount to $2,000 significantly raises uncertainty for the days ahead, but our base case remains that the bill passed by Congress will become law."
They don't, however, believe that a version with $2,000 checks is imminent.
"The package passed both the House and the Senate with veto-proof margins and the $2,000 payment level (the Democrats' original proposal in the HEROES Act) has no support among Republican lawmakers," they say.
It's also possible that so-called Biden stocks could ultimately benefit from this outburst, as it seems to tip the scales of the Georgia Senate runoffs – would determine whether President-elect Joe Biden has an acquiescent Congress to work with over at least the next two years.
"Further, the President's demand is arguably a net positive for Democrats' chances in the Georgia Senate races," Raymond James analysts say, "as Republicans will be forced on the defensive on support for the $2,000 checks and any delay on COVID relief."
(Stay on top of all the new stimulus bill developments – sign up for the FREE Kiplinger Today E-Newsletter!)
-
Disney’s Risky Acceptance of AI VideosThe Kiplinger Letter Disney will let fans run wild with AI-generated videos of its top characters. The move highlights the uneasy partnership between AI companies and Hollywood.
-
Ask the Editor: Itemized DeductionsAsk the Editor In this week's Ask the Editor Q&A, Joy Taylor answers questions on itemized deductions claimed on Schedule A of Form 1040
-
9 Types of Insurance You Don't NeedFinancial Planning If you're paying for these types of insurance, you may be wasting your money. Here's what you need to know.
-
If You'd Put $1,000 Into Coca-Cola Stock 20 Years Ago, Here's What You'd Have TodayEven with its reliable dividend growth and generous stock buybacks, Coca-Cola has underperformed the broad market in the long term.
-
If You Put $1,000 into Qualcomm Stock 20 Years Ago, Here's What You Would Have TodayQualcomm stock has been a big disappointment for truly long-term investors.
-
If You'd Put $1,000 Into Home Depot Stock 20 Years Ago, Here's What You'd Have TodayHome Depot stock has been a buy-and-hold banger for truly long-term investors.
-
If You'd Put $1,000 Into Bank of America Stock 20 Years Ago, Here's What You'd Have TodayBank of America stock has been a massive buy-and-hold bust.
-
If You'd Put $1,000 Into Oracle Stock 20 Years Ago, Here's What You'd Have TodayORCL Oracle stock has been an outstanding buy-and-hold bet for decades.
-
If You'd Put $1,000 Into Sherwin-Williams Stock 20 Years Ago, Here's What You'd Have TodaySherwin-Williams stock has clobbered the broader market by a wide margin for a long time.
-
If You'd Put $1,000 Into UnitedHealth Group Stock 20 Years Ago, Here's What You'd Have TodayUNH stock was a massive market beater for ages — until it wasn't.
-
If You'd Put $1,000 Into Berkshire Hathaway Stock 20 Years Ago, Here's What You'd Have TodayBerkshire Hathaway is a long-time market beater, but the easy money in BRK.B has already been made.
